ON-108600

N/A

Report date: 2024/04/08 17:12:13

NME

Base Information

Drug NameON-108600

Drug Alias NameON-108600

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionCasein kinase II inhibitorsTRAF2 and NCK-interacting protein kinase inhibitorsDual-specificity tyrosine-phosphorylation regulated kinase 1A inhibitors

TargetsCasein kinase IITRAF2 and NCK-interacting protein kinaseDual-specificity tyrosine-phosphorylation regulated kinase 1A

Therapy Area/IndicationsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesTraws Pharma Inc

China Registration ClassN/A

Develop Information

Active CompaniesTraws Pharma Inc

Inactive CompaniesN/A

Active IndicationsBreast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A